A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

A family can sue the California Highway Patrol over an incident in which an officer missed the signs of an accident victim's ...

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

Researchers at the University of Maryland identified a potential link between early-onset ischemic stroke and a genetic ...

American Stroke Association unveils guidelines that could prevent up to 80% of strokes through eight essential lifestyle ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

Renn Asia Wellness, a Malaysian holistic healthcare centre, is offering complementary ways to tackle stroke care and ...

The ambulance would be the latest addition to Florida’s first mobile stroke treatment unit network, which speeds care to ...

A report has warned that stroke victims are facing a postcode lottery to access lifesaving treatment. The Stroke Association ...